Self-Directed Biological Transformation Initiative (SBTI)

December 14, 2015 updated by: Paul J. Mills, University of California, San Diego
It is becoming increasingly recognized in the literature that ancient practices for wellbeing, including meditation, yoga, and specific herbs, can improve health and promote longevity. While studies have documented such effects for a variety of individual practices for wellbeing, few studies have taken a more whole systems approach that is simultaneously inclusive of numerous practices. This intervention study, the "Self-Directed Biological Transformation Initiative", will examine the effects of a comprehensive whole systems approach to wellbeing on key biochemical, physiological, and psychosocial endpoints. Participants randomized to the Perfect Health program at the Chopra Center for Wellbeing will be compared to individuals not taking the program.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

SPECIFIC AIMS

  1. To examine the effects of the Self-Directed Biological Transformation Initiative (SBTI) course participants compared to control group participants on key biochemical and physiological markers.
  2. To examine the effects of the SBTI course participants compared to control group participants on short- and long-term changes in heart rate variability, level of activity, and sleep quality.
  3. To examine the effects of the SBTI course participants as compared to control group participants on mood and wellbeing.

BACKGROUND AND SIGNIFICANCE It has long been thought that ancient practices can promote longevity and wellbeing but there is little empirical evidence and it is difficult to test this under controlled or experimental conditions. Recently, however, there have been several cellular-based markers that may index rate of biological aging. The rate of telomere shortening, as indexed by change in telomere length and telomerase activity, predicts both cellular and human longevity (Lin et al, 2012). It is related to malleable factors, lifestyle and psychological state (Puterman & Epel, 2012). A secondary measure that shows promise of understanding rate of cellular aging is examination of gene expression, particularly genes related to aging. Preliminary evidence suggests that mind-body practices may slow the rate of cellular aging by improving the telomere/telomerase maintenance system. This has been examined in four small studies so far.

In the first study of its kind, a four month intensive lifestyle modification program, including yoga and group support was associated with an increase in telomerase in 39 men with prostate cancer (in preparation). There was no control group in this study. However, those with the greatest decreases in distressing thoughts about having cancer showed the biggest increases in telomerase activity (Ornish et al, 2008). In a second study, healthy men and women were randomized to a 3-month intensive in-residence meditation group or wait list control group. The researchers examined telomerase only post intervention and found that the meditation group had 30% higher telomerase, and further increases in wellbeing were associated with increases in telomerase (Jacobs et al, 2011). In another study with an active control group, examined 39 elderly high stress dementia caregivers. They randomized half the group to Yoga Nidra, listening to a 15 minute tape each day of Yoga Nidra, which includes instruction on breathing and hand movements and half to a control group which listened to a relaxation tape for 15 minutes each day. Eight weeks later, they found greater telomerase increases in the Yoga Nidra group, and across the sample, decreases in depressive symptoms were associated with increases in telomerase activity (Lavretsky et al, 2013).

Similar studies have reported positive effects of such practices on inflammatory profiles and gene expression (Tang, Ma et al. 2009, Bhasin, Dusek et al. 2013, Saatcioglu 2013). Another well studied parameter for practices such as meditation and yoga is heart rate variability (HRV) as it provides a broad measure of autonomic nervous system activity. Observational studies report HRV to be associated with stress in the workplace,(Jarczok, Jarczok et al. 2013) depressive and anxiety disorders (Gorman and Sloan 2000), and in individuals with chronic somatic complaints (Tak, Riese et al. 2009). Meditation and yoga interventions to improve HRV can lead to improved physiologic and clinical outcomes (Wheat and Larkin 2010, Papp, Lindfors et al. 2013). Other parameters can also be of potential benefit in evaluating an individual's overall wellbeing. For example, sleep duration and quality, as well as general activity levels can both contribute to and reflect overall wellbeing. To date, however, lack of compelling data around objective measures of wellbeing is in large part due to challenges associated with long term monitoring of monitoring of appropriate patient populations. However, recent advances in biosensor technologies have overcome this limitation and now allow for the non-obtrusive and passive monitoring of individuals for long periods of time. These new data streams of real-time physiologic data, couple with sophisticated and individualized data analytics can potentially identify novel measures of individual wellness, which will allow for the development of personalized therapeutic interventions to improve wellbeing.

Overall, while the results of many of the studies of traditional practices are compelling, in reality, and according the more whole system approaches such as Ayurveda and Chines Medicine, traditional practices are rarely practiced singularly, i.e, typically yoga asanas are practiced with meditation as well as a form of pranayama (breathing). With this consideration, few scientific studies have taken a more comprehensive "whole systems" approach that is simultaneously inclusive of numerous practices. Regarding outcomes, this study will take a systems biology approach to examining the biochemical, physiological, and psychosocial effects of the intervention. It is anticipated that the findings will demonstrate the value of taking a more inclusive and comprehensive whole systems approach to improving wellbeing and improved health.

Study Type

Interventional

Enrollment (Actual)

115

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Carlsbad, California, United States, 92009
        • Chopra Center for Wellbeing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Men and women between the ages of 40-80 years

    Exclusion Criteria:

  2. Self-reported diagnosis of a major medical condition, such as cancer (including those who have received past radiation or chemotherapy treatment), heart disease, autoimmune disease, or diabetes, as these can affect the cell aging system and possibly the ability for telomerase to change in short periods
  3. Individuals taking antidepressant medication will be excluded since such medication appears to increase telomerase (Wolkowitz et al, 2010)
  4. Individuals with diagnosed PTSD will be excluded; there is evidence that those with PTSD may have lower telomere length as compared to those without PTSD (O'Donovan et al, 2011). It is currently unknown how PTSD may impact telomerase levels
  5. Estrogen use is excluded as it increases telomerase (Lin et al, 2011)
  6. Smokers will be excluded since smoking decreases telomerase. We will base smoking status on self report. If participants have not smoked regularly for the past 6 months, they will be considered a 'non-smoker
  7. Pregnant women are excluded since the cell aging system changes during pregnancy in ways that have not been studied
  8. Participants with a Body Mass Index (BMI) of 35 or greater will be excluded due to differences in telomerase activity in obese women
  9. Potential eligible participants who are unable to secure the week off from work or other responsibilities will not be enrolled
  10. Known atrial fibrillation or other chronic dysrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Perfect health course
Perfect health course at the Chopra Center for Wellbeing
The Perfect Health course as taught at the Chopra Center for Wellbeing
No Intervention: Resort group
Resort group at the La Costa resort

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in RNA expression
Time Frame: Assessed pre and post 7 day intervention
Blood samples will be collected for RNA expression and assayed using standardized methodologies
Assessed pre and post 7 day intervention
Change in cytokine levels
Time Frame: Assessed pre and post 7 day intervention
Blood samples will be collected for inflammatory cytokine levels and determined via standardized ELISA methods
Assessed pre and post 7 day intervention
Change in telomerase activity
Time Frame: Assessed pre and post 7 day intervention
Blood samples will be collected for PBMC telomerase activity and assayed using standardized methodologies
Assessed pre and post 7 day intervention
Change in neurohormome levels
Time Frame: Assessed pre and post 7 day intervention
Blood and saliva samples will be collected for neurohormone levels and be determined via standardized ELISA methods
Assessed pre and post 7 day intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in heart rate variability
Time Frame: Assessed pre and post 7 day intervention and one month follow-up
ECG activity will be obtained via continuous wearable wireless sensor
Assessed pre and post 7 day intervention and one month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in quality of life
Time Frame: Assessed pre and post 7 day intervention and one month follow-up
A set of standardized and validated questionnaires will be administered
Assessed pre and post 7 day intervention and one month follow-up
Change in gut microbiome populations
Time Frame: Assessed pre and post 7 day intervention and one month follow-up
Stool samples will be collected to determine gut microbiome using standardized methodologies
Assessed pre and post 7 day intervention and one month follow-up
Change in mood
Time Frame: Assessed pre and post 7 day intervention and one month follow-up
A set of standardized and validated questionnaires will be administered
Assessed pre and post 7 day intervention and one month follow-up
Change in spiritual wellbeing
Time Frame: Assessed pre and post 7 day intervention and one month followup
A set of standardized and validated questionnaires will be administered
Assessed pre and post 7 day intervention and one month followup

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Murali Doraiswamy, MD, Duke University
  • Principal Investigator: Elizabeth Blackburn, PhD, University of California, San Francisco
  • Study Director: Paul J Mills, PHD, University of California, San Diego
  • Study Chair: Rudolph E Tanzi, PhD, Harvard University
  • Study Chair: Deepak Chopra, MD, Chopra Center for Wellbeing & University of California, San Diego
  • Principal Investigator: Sheila Patel, MD, Chopra Center for Wellbeing & University of California, San Diego
  • Principal Investigator: Valencia Porter, MD, Chopra Center for Wellbeing & University of California, San Diego
  • Principal Investigator: Eric Schadt, PhD, Mount Sinai Hospital
  • Principal Investigator: Steven Steinhubl, MD, Scripps Translational Science Institute, Scripps Research Institute
  • Principal Investigator: Eric Topel, MD, Scripps Translational Science Institute, Scripps Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

February 1, 2015

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

September 9, 2014

First Submitted That Met QC Criteria

September 12, 2014

First Posted (Estimate)

September 16, 2014

Study Record Updates

Last Update Posted (Estimate)

December 16, 2015

Last Update Submitted That Met QC Criteria

December 14, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • SBTI

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Perfect Health Course

3
Subscribe